In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium

Scattered inflammatory cells are commonly observed in mammary gland tissue, most likely in response to normal cell turnover by proliferation and apoptosis, or as part of immunosurveillance. In contrast, lymphocytic lobulitis (LLO) is a recurrent inflammation pattern, characterized by lymphoid cells infiltrating lobular structures, that has been associated with increased familial breast cancer risk and immune responses to clinically manifest cancer. The mechanisms and pathogenic implications related to the inflammatory microenvironment in breast tissue are still poorly understood. Currently, the definition of inflammation is mainly descriptive, not allowing a clear distinction of LLO from physiological immunological responses and its role in oncogenesis remains unclear. To gain insights into the prognostic potential of inflammation, we developed an agent-based model of immune and epithelial cell interactions in breast lobular epithelium. Physiological parameters were calibrated from breast tissue samples of women who underwent reduction mammoplasty due to orthopedic or cosmetic reasons. The model allowed to investigate the impact of menstrual cycle length and hormone status on inflammatory responses to cell turnover in the breast tissue. Our findings suggested that the immunological context, defined by the immune cell density, functional orientation and spatial distribution, contains prognostic information previously not captured by conventional diagnostic approaches.

[1]  T. Anderson,et al.  Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. , 1988, The American journal of pathology.

[2]  Alan Mackay,et al.  Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. , 2004, Cancer research.

[3]  Mina J. Bissell,et al.  Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and Neoplasia , 2005, Journal of Mammary Gland Biology and Neoplasia.

[4]  R. Guzman,et al.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Maier,et al.  Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle , 2005, Breast Cancer Research.

[6]  T. Anderson,et al.  Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. , 1981, British Journal of Cancer.

[7]  K. Lohman,et al.  DNA damage and breast cancer risk. , 2003, Carcinogenesis.

[8]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[9]  J. Russo,et al.  Histological Evaluation of the Normal Breast , 2014 .

[10]  F. Rodier,et al.  DDR-mediated crosstalk between DNA-damaged cells and their microenvironment , 2015, Front. Genet..

[11]  Michael R. Elliott,et al.  Clearance of apoptotic cells: implications in health and disease , 2010, The Journal of cell biology.

[12]  S. Cullen,et al.  Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells. , 2013, Molecular cell.

[13]  D. Dudley,et al.  The immune system in health and disease. , 1992, Bailliere's clinical obstetrics and gynaecology.

[14]  W. Zou Regulatory T cells, tumour immunity and immunotherapy , 2006, Nature Reviews Immunology.

[15]  T. Nielsen,et al.  The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  P. Norman,et al.  Immunobiology: The immune system in health and disease , 1995 .

[17]  E. Sandgren,et al.  Mammary carcinogenesis is preceded by altered epithelial cell turnover in transforming growth factor-alpha and c-myc transgenic mice. , 2006, The American journal of pathology.

[18]  P. Unterberger,et al.  Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History , 2004, Breast Cancer Research and Treatment.

[19]  Jens V Stein,et al.  How chemokines invite leukocytes to dance , 2008, Nature Immunology.

[20]  Karin Jirström,et al.  Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.

[21]  L. Beck,et al.  Chemokines: key players in innate and adaptive immunity. , 2005, The Journal of investigative dermatology.

[22]  Kornelia Polyak,et al.  Breast cancer: origins and evolution. , 2007, The Journal of clinical investigation.

[23]  E. Ranieri Cytotoxic T-Cells , 2014, Methods in Molecular Biology.

[24]  R. Vierkant,et al.  Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues , 2012, Breast Cancer Research and Treatment.

[25]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[26]  L. Coussens,et al.  Leukocytes in mammary development and cancer. , 2011, Cold Spring Harbor perspectives in biology.

[27]  Karin Jirström,et al.  The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients , 2012, BMC Cancer.

[28]  G. Garinis,et al.  DNA damage and innate immunity: links and trade-offs. , 2014, Trends in immunology.

[29]  A. Douglas-Jones,et al.  Lymphocytic lobulitis in breast core biopsy: a peritumoral phenomenon , 2006, Histopathology.

[30]  Carsten Denkert,et al.  Clinical relevance of host immunity in breast cancer: from TILs to the clinic , 2016, Nature Reviews Clinical Oncology.

[31]  M. Erlacher,et al.  How cell death shapes cancer , 2015, Cell Death and Disease.

[32]  G. Feldman,et al.  Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2 , 2010, Genetics in Medicine.

[33]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[34]  S. Narod Modifiers of risk of hereditary breast cancer , 2006, Oncogene.

[35]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[36]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[37]  David Depoil,et al.  Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Derek C. Radisky,et al.  Immune cell quantitation in normal breast tissue lobules with and without lobulitis , 2014, Breast Cancer Research and Treatment.

[39]  Nicolas Brieu,et al.  Slide-specific models for segmentation of differently stained digital histopathology whole slide images , 2016, SPIE Medical Imaging.

[40]  L. Happerfield,et al.  Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. , 1996, British Journal of Cancer.

[41]  A. Thor,et al.  Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  Craig Murdoch,et al.  The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.

[43]  A. Ribas,et al.  The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? , 2015, Current opinion in immunology.

[44]  G. Collins The next generation. , 2006, Scientific American.

[45]  D. Green,et al.  To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate , 2014, Cell.

[46]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[47]  Sylvain V Costes,et al.  Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies , 2010, Breast Cancer Research.

[48]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[49]  P. Glazer,et al.  Interplay between DNA repair and inflammation, and the link to cancer , 2014, Critical reviews in biochemistry and molecular biology.

[50]  A. Andres,et al.  Apoptosis in the Estrous and Menstrual Cycles , 1999, Journal of Mammary Gland Biology and Neoplasia.

[51]  Cathrin Brisken,et al.  Progesterone signalling in breast cancer: a neglected hormone coming into the limelight , 2013, Nature Reviews Cancer.

[52]  Celeste M. Nelson,et al.  Integrated morphodynamic signalling of the mammary gland , 2011, Nature Reviews Molecular Cell Biology.

[53]  R. Chetty,et al.  Lymphocytic mastopathy associated with infiltrating lobular breast carcinoma. , 1993, Journal of clinical pathology.

[54]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Pollard Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[56]  E. Tartour,et al.  Immune infiltration in human tumors: a prognostic factor that should not be ignored , 2010, Oncogene.

[57]  Lisa M. Coussens,et al.  Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression , 2007 .

[58]  S. Powell,et al.  BRCA1 and BRCA2: different roles in a common pathway of genome protection , 2011, Nature Reviews Cancer.

[59]  Paul J van Diest,et al.  Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer , 2005, The Journal of pathology.

[60]  Seema A. Khan,et al.  Morphological Changes in Breast Tissue with Menstrual Cycle , 2002, Modern Pathology.

[61]  C. Caldon,et al.  Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers , 2014, Front. Oncol..

[62]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[63]  E. Thompson,et al.  Hormonal regulation of physiological cell turnover and apoptosis , 2000, Cell and Tissue Research.

[64]  A. Howell,et al.  The effect of age and menstrual cycle upon proliferative activity of the normal human breast. , 1988, British Journal of Cancer.

[65]  M. Coffey,et al.  DNA mismatch repair and the transition to hormone independence in breast and prostate cancer. , 2010, Cancer letters.

[66]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[67]  L. Coussens,et al.  Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression , 2007, Breast Cancer Research.

[68]  Ian O Ellis,et al.  Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  I. Weissman,et al.  Programmed cell removal: a new obstacle in the road to developing cancer , 2011, Nature Reviews Cancer.

[70]  V. Band,et al.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[72]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[73]  Z. Werb,et al.  Roles of the Innate Immune System in Mammary Gland Remodeling During Involution , 2007, Journal of Mammary Gland Biology and Neoplasia.

[74]  S. Ostrand-Rosenberg,et al.  Immune surveillance: a balance between protumor and antitumor immunity. , 2008, Current opinion in genetics & development.

[75]  J. Russo,et al.  Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland , 1999, Breast Cancer Research and Treatment.

[76]  G. Merlino Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice. , 1994, Seminars in cancer biology.

[77]  G. Raab,et al.  Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. , 1982, British Journal of Cancer.

[78]  Mark J. Smyth,et al.  Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.

[79]  Antje Sommer,et al.  Theory Of Simple Liquids , 2016 .

[80]  R. Dymock Origins and Evolution , 2010 .

[81]  Gavin P Dunn,et al.  Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. , 2006, Advances in immunology.

[82]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[83]  Katherine M White,et al.  A randomised controlled trial of a theory-based intervention to improve sun protective behaviour in adolescents ('you can still be HOT in the shade'): study protocol , 2012, BMC Cancer.

[84]  Bernhard Moser,et al.  Lymphocyte traffic control by chemokines , 2001, Nature Immunology.

[85]  C. Sweeney,et al.  Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancer. , 2014, Human Pathology.

[86]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[87]  C. Janeway Immunobiology: The Immune System in Health and Disease , 1996 .